A bill establishing a procedure for regulation of prices for vital and essential medicines has become law. A version of the document signed by Russian President Vladimir Putin has been published on the official website of legal information.
The law stipulates binding reregistration of producers’ maximum sale prices for vital and essential drugs if their price has been reduced in a producing country and in the states where these medicines have been registered.
It also envisages that the producer’s registered maximum sale price for such drugs may be rerecorded increasingly not more frequently than once a year.
Amendments will be introduced into the law on medicine circulation.